R1 RCM
R1 RCM is a technology-enabled revenue cycle management provider for hospitals, health systems and physician groups, covering patient registration, benefits verification, coding, billing and collections at roughly $2.1B annual revenue. It was taken private by [Your firm] and Clayton, Dubilier & Rice in November 2024.
Why interesting to a deal team
TowerBrook and CD&R's $8.9B take-private of R1 is the largest sponsor-led healthcare IT buyout; the connected experts span CD&R's board-level deal lead and M&A counsel on both the buyout and the Phare Health bolt-on, giving a deal team the full working group.
Experts connected to this company
- Ravi SachdevCD&R deal lead on $8.9B take-private; board member
- Robert HaywardLed Kirkland team advising R1 on $8.9B take-private
- Nicholas FerrerM&A counsel to R1 on Phare Health acquisition
Ravi Sachdev
Partner
Clayton, Dubilier & Rice
CD&R's healthcare deal lead and co-architect of the $8.9B R1 RCM take-private — the single most consequential GP in healthcare RCM private equity today.
Robert Hayward
Corporate Partner (led legal team advising R1 RCM on its $8.9B acquisition by TowerBrook and CD&R)
Kirkland & Ellis LLP
Kirkland's lead corporate partner on R1 RCM's $8.9B take-private by TowerBrook and CD&R — he knows that deal's structure, board process and sponsor counterparties firsthand.
Nicholas Ferrer
Partner and Co-Chair of the firm-wide M&A practice (led the Perkins Coie team advising R1 RCM on its $675M acquisition of Acclara)
Ashurst Perkins Coie
Co-chairs M&A at Ashurst Perkins Coie and is R1's repeat deal counsel, giving him a direct read on healthcare RCM buy-side activity and Seattle middle-market sponsors.
Sources
- No name matchPrimaryBot-blockedr1rcm.com/newsroom/r1-rcm-to-be-acquired-by-towerbrook-and-cdr-for-8-9-billion
- Page titleOtheren.wikipedia.org/wiki/R1_RCM
- Structured dataPrimaryArchived 2026-07-26r1rcm.com